Migraine drug trial halted midway: what happened?
Symptom relief
Terminated
This study tested an experimental drug called K-645 for people having migraine attacks. It included 134 adults aged 18 to 65 with a history of migraines. The goal was to see if the drug could stop pain and other bothersome symptoms better than a placebo. However, the trial was te…
Phase: PHASE2 • Sponsor: Kallyope Inc. • Aim: Symptom relief
Last updated Apr 26, 2026 20:03 UTC